Loading...

TNYA TENAYA THERAPEUTICS INC Management Changes 8-K Filing

TNY

TNY

TENAYA THERAPEUTICS INC

(TNYA)

2025 8-K

Show Summary

Show Summary

Financial Statements

Nasdaq Compliance

Restructuring Plan

Earnings Announcement

Public Offering

Management Changes

Stock Option Repricing

Clinical Trial Update

Management Change

Earnings Announcement

Financial Results and Manag...

Resignation of CFBO

Resignation of Director

Annual Meeting and Voting R...

Financial Results and Workf...

Earnings Reports

Underwriting Agreement for ...

Earnings Reports

Earnings Reports

Amendments to Executive Sev...

Earnings Reports

Amended and Restated Bylaws

Regulation FD Disclosure

Earnings Reports

External Links:

Tenaya Therapeutics appointed Tomohiro Higa as Interim Principal Accounting Officer and repriced CEO Faraz Ali's stock options from $5.64-$15.19 to $1.21 per share, affecting approximately 915,875 shares.

AI Assistant

TENAYA THERAPEUTICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.